ELVN
Elvn is a first messenger which rewards for activity.
ELVN
Industry:
Information Technology Internet Messaging Software
Address:
Mong Kok, Kowloon, Hong Kong
Country:
Hong Kong
Website Url:
http://www.elvn.com
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Apple Mobile Web Clips Icon Apache Nginx Apache 2.4 Debian Comodo SSL
Similar Organizations
Essentially Precise SMS
Essentially Precise SMS is a Mobile Messaging & Digital Marketing Agency.
Current Employees Featured
Founder
Newest Events participated
Official Site Inspections
http://www.elvn.com
- Host name: 23.111.25.139
- IP address: 23.111.25.139
- Location: Netherlands
- Latitude: 52.3824
- Longitude: 4.8995
- Timezone: Europe/Amsterdam
More informations about "Elvn"
Leadership | Board of Directors | Scientific Advisors | Enliven ...
Anish is a co-founder of Enliven Therapeutics and serves as the Chief Operating Officer. Prior to co-founding Enliven, Anish was the Head of Medical Affairs at AbbVie Stemcentrx, where he …See details»
Elvn - Crunchbase Company Profile & Funding
Organization. Elvn . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. Elvn is a first messenger which rewards for activity. ... Alternatives and possible competitors to Elvn may …See details»
Enliven Therapeutics Announces $90 Million Private Placement …
Mar 19, 2024 Net proceeds, along with existing cash, cash equivalents and marketable securities, are expected to extend cash runway into late 2026 and through multiple key clinical …See details»
Enliven Therapeutics, Inc. (ELVN) Company Profile & Overview
Mar 12, 2020 The company’s lead product candidates comprise ELVN-001, which is being evaluated in a Phase 1 clinical trial in adults with chronic myeloid leukemia; and ELVN-002, a …See details»
Enliven Therapeutics, Inc. (ELVN) - Yahoo Finance Canada
The company's lead product candidates comprise ELVN-001, which is being evaluated in a Phase 1 clinical trial in adults with chronic myeloid leukemia; and ELVN-002, a Phase 1 clinical trial in …See details»
Elvn Company Profile | Management and Employees List - Datanyze
Elvn Profile and History. Elvn Inc is a company that operates in the Information Technology and Services industry. It employs 6-10 people and has $1M-$5M of revenue. The company is …See details»
Enliven Therapeutics, Inc. (ELVN) - Yahoo Finance
Find the latest Enliven Therapeutics, Inc. (ELVN) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
ELVN | Enliven Therapeutics Inc. Profile | MarketWatch
ELVN Profile. Company Profile. Enliven Therapeutics Inc. 6200 Lookout Road. Boulder, Colorado 80301 . Phone 1 720 647-8519. Industry Biotechnology; Sector Health Care/Life Sciences; …See details»
Elvn
Elvn main logo. About; App; Contacts; Download; First messenger which rewards for activity! Send me a link. Our Advantages. Built-in social network. Built-in crypto wallet. All for comfortable communication. Activity bonuses in …See details»
Enliven Therapeutics (ELVN) Stock Price, News & Analysis
5 days ago Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. The …See details»
Release Details - Enliven Therapeutics
ELVN-001 is being evaluated in a Phase 1 clinical trial in adults with CML. To learn more, please visit www.clinicaltrials.gov ( NCT05304377 ). ELVN-002 : a potent, selective and irreversible …See details»
Enliven Therapeutics, Inc. (ELVN) - Stock Analysis
5 days ago Enliven Therapeutics Reports Third Quarter Financial Results and Provides a Business Update. Announced positive data from the Phase 1 clinical trial of ELVN-001 in CML, …See details»
Enliven Therapeutics Reports Third Quarter Financial Results and ...
Nov 13, 2024 Announced positive data from the Phase 1 clinical trial of ELVN-001 in CML, reporting a cumulative MMR rate of 44% (8/18) by 24 weeks and showing that ELVN-001 …See details»
Enliven Therapeutics (ELVN) Earnings Date and Reports 2025
5 days ago Enliven Therapeutics (NASDAQ:ELVN) has a recorded net income of -$71.58 million. ELVN has generated -$1.90 earnings per share over the last four quarters. What is …See details»
ELVN Stock Price Quote - Morningstar
Dec 4, 2024 Enliven Therapeutics Announces Details Regarding the Presentation of Updated ELVN-001 Phase 1a Data at the ESH-iCMLf 26th Annual John Goldman Conference on CML. …See details»
ELVN Digital - Crunchbase Company Profile & Funding
ELVN Digital is located in Las Vegas, Nevada, United States. Who are ELVN Digital 's competitors? Alternatives and possible competitors to ELVN Digital may include Breaking …See details»
Enliven Therapeutics Shares First Look At Safety, Clinical Activity Of ...
Apr 11, 2024 ELVN-001 is a small molecule kinase inhibitor designed to specifically target the BCR-ABL gene fusion, the oncogenic driver for patients with CML. “We are excited to present …See details»
ELVN Stock Price and Chart - ChartExchange
Dec 3, 2024 ELVN Stock Summary. Enliven Therapeutics Inc (NASDAQ:ELVN) stock price today is $24.23, and today's volume is 13,827. ELVN is down -0.819% today. The 30 day …See details»
Enliven Therapeutics, Inc. (ELVN) Stock Price, Quote, News & Analysis
5 days ago A high-level overview of Enliven Therapeutics, Inc. (ELVN) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.See details»